Dobutamine: Absolute Contraindications and Safety Management

Absolute Structural Contraindications

• Critical aortic stenosis and hemodynamically significant left‑ventricular outflow‑tract (LVOT) obstruction are absolute contraindications to dobutamine, for both therapeutic infusion and stress‑testing protocols. 1, 2
• Dobutamine’s positive inotropic effect can markedly exacerbate dynamic LVOT obstruction, increasing the risk of severe hemodynamic compromise in affected patients. 3, 4

Contraindications for Dobutamine Stress Testing

Acute Coronary and Heart‑Failure Conditions

• Active acute coronary syndrome or myocardial infarction within the preceding 2 days precludes the use of dobutamine stress testing. 3, 4
• Decompensated heart failure is a contraindication to dobutamine stress testing. 1, 2

Arrhythmias and Blood‑Pressure Extremes

• Uncontrolled arrhythmias, including severe ventricular arrhythmias, contraindicate dobutamine stress testing. 1, 3, 4
• Severe systemic hypertension (systolic ≥ 200 mm Hg or diastolic ≥ 110 mm Hg) is a contraindication to dobutamine stress testing. 1, 2, 3

Other Acute Cardiovascular Emergencies

• Acute aortic dissection is an absolute contraindication to dobutamine administration. 1, 2, 3
• Acute pericarditis or myocarditis precludes the use of dobutamine. 1, 2, 3
• Acute pulmonary embolism is a contraindication to dobutamine stress testing. 1, 3
• Severe pulmonary hypertension contraindicates dobutamine use. 1, 2

Management of Adverse Reactions During Dobutamine Infusion

• If progressive hypotension or arrhythmias develop after initiating dobutamine, the infusion should be promptly reduced or discontinued. 5, 6, 7
• Esmolol (10 mg/mL) at a dose of 0.5 mg/kg should be readily available to rapidly reverse dobutamine‑induced adverse effects or ischemia. 8